Universe Pharmaceuticals Stock Performance

UPC Stock  USD 3.98  0.41  9.34%   
On a scale of 0 to 100, Universe Pharmaceuticals holds a performance score of 4. The entity has a beta of -0.79, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Universe Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Universe Pharmaceuticals is likely to outperform the market. Please check Universe Pharmaceuticals' value at risk, as well as the relationship between the accumulation distribution and day typical price , to make a quick decision on whether Universe Pharmaceuticals' existing price patterns will revert.

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Universe Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting basic indicators, Universe Pharmaceuticals exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

Five Day Return
(4.33)
Year To Date Return
(4.33)
Ten Year Return
(99.98)
All Time Return
(99.98)
Last Split Factor
1:40
Last Split Date
2025-03-24
1
Universe Pharmaceuticals Trading Down 2.4 percent Whats Next
11/12/2025
2
Why Universe Pharmaceuticals INC stock is seen as undervalued - Portfolio Growth Summary Consistent Return Investment Signals - newser.com
11/19/2025
3
Disposition of tradable shares by Lewis Parnell S Jr of Universe Pharmaceuticals subject to Rule 16b-3
12/05/2025
4
UPC Stock Surges Amid Strategic Announcements - StocksToTrade
12/26/2025
5
Chinese Stocks To Follow Today - December 29th - MarketBeat
12/29/2025
6
Risk Report Can Universe Pharmaceuticals INC stock sustain free cash flow growth - moha.gov.vn
01/13/2026
7
Acquisition by Moore Jackson W of 20334 shares of Universe Pharmaceuticals at 31.83 subject to Rule 16b-3
01/16/2026
8
Energy Moves Can Universe Pharmaceuticals INC disrupt its industry - Portfolio Return Summary Reliable Entry Point Alerts - baoquankhu1.vn
02/02/2026
Begin Period Cash Flow29.5 M
Total Cashflows From Investing Activities-341.8 K

Universe Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  370.00  in Universe Pharmaceuticals on November 9, 2025 and sell it today you would earn a total of  28.00  from holding Universe Pharmaceuticals or generate 7.57% return on investment over 90 days. Universe Pharmaceuticals is generating 0.3649% of daily returns assuming volatility of 7.2174% on return distribution over 90 days investment horizon. In other words, 64% of stocks are less volatile than Universe, and above 93% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Universe Pharmaceuticals is expected to generate 8.81 times more return on investment than the market. However, the company is 8.81 times more volatile than its market benchmark. It trades about 0.05 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Universe Pharmaceuticals Target Price Odds to finish over Current Price

The tendency of Universe Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 3.98 90 days 3.98 
about 56.11
Based on a normal probability distribution, the odds of Universe Pharmaceuticals to move above the current price in 90 days from now is about 56.11 (This Universe Pharmaceuticals probability density function shows the probability of Universe Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Universe Pharmaceuticals has a beta of -0.79. This usually implies as returns on the benchmark increase, returns on holding Universe Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, Universe Pharmaceuticals is likely to outperform the market. Additionally Universe Pharmaceuticals has an alpha of 0.0314, implying that it can generate a 0.0314 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Universe Pharmaceuticals Price Density   
       Price  

Predictive Modules for Universe Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Universe Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.224.4611.68
Details
Intrinsic
Valuation
LowRealHigh
0.183.6710.89
Details
Naive
Forecast
LowNextHigh
0.084.0311.25
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3.384.114.84
Details

Universe Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Universe Pharmaceuticals is not an exception. The market had few large corrections towards the Universe Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Universe Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Universe Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.03
β
Beta against Dow Jones-0.79
σ
Overall volatility
0.39
Ir
Information ratio -0.02

Universe Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Universe Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Universe Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Universe Pharmaceuticals had very high historical volatility over the last 90 days
Universe Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
The company reported the last year's revenue of 17.86 M. Reported Net Loss for the year was (3.67 M) with profit before taxes, overhead, and interest of 6.3 M.
Universe Pharmaceuticals has about 28.58 M in cash with (5.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31.
Latest headline from news.google.com: Energy Moves Can Universe Pharmaceuticals INC disrupt its industry - Portfolio Return Summary Reliable Entry Point Alerts - baoquankhu1.vn

Universe Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Universe Stock often depends not only on the future outlook of the current and potential Universe Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Universe Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding3478.00
Cash And Short Term Investments33.6 M

Universe Pharmaceuticals Fundamentals Growth

Universe Stock prices reflect investors' perceptions of the future prospects and financial health of Universe Pharmaceuticals, and Universe Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Universe Stock performance.

About Universe Pharmaceuticals Performance

By analyzing Universe Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Universe Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Universe Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Universe Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 79.65  73.18 
Return On Tangible Assets(0.06)(0.06)
Return On Capital Employed(0.06)(0.06)
Return On Assets(0.06)(0.06)
Return On Equity(0.08)(0.07)

Things to note about Universe Pharmaceuticals performance evaluation

Checking the ongoing alerts about Universe Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Universe Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Universe Pharmaceuticals had very high historical volatility over the last 90 days
Universe Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
The company reported the last year's revenue of 17.86 M. Reported Net Loss for the year was (3.67 M) with profit before taxes, overhead, and interest of 6.3 M.
Universe Pharmaceuticals has about 28.58 M in cash with (5.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31.
Latest headline from news.google.com: Energy Moves Can Universe Pharmaceuticals INC disrupt its industry - Portfolio Return Summary Reliable Entry Point Alerts - baoquankhu1.vn
Evaluating Universe Pharmaceuticals' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Universe Pharmaceuticals' stock performance include:
  • Analyzing Universe Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Universe Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
  • Examining Universe Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Universe Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Universe Pharmaceuticals' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Universe Pharmaceuticals' stock. These opinions can provide insight into Universe Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Universe Pharmaceuticals' stock performance is not an exact science, and many factors can impact Universe Pharmaceuticals' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Universe Stock analysis

When running Universe Pharmaceuticals' price analysis, check to measure Universe Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universe Pharmaceuticals is operating at the current time. Most of Universe Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Universe Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universe Pharmaceuticals' price. Additionally, you may evaluate how the addition of Universe Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Transaction History
View history of all your transactions and understand their impact on performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk